Zhongnan Medical Journal Press

Home Results

A total of 11 result was found. Results that relate to Heart failure

Dapagliflozin in the treatment of chronic heart failure: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2023,32(5):554-563.
9068 times 1904 times

An-Hua WEI Lu WANG Lu ZENG Xue-Peng GONG Dong LIU

Dapagliflozin Chronic heart failure Effectiveness Safety Economy Rapid health technology assessment
Details
Cost-utility analysis of sacubitril/valsartan, dapagliflozin and empagliflozin in heart failure with reduced ejection fraction

Published on Chinese Journal of Pharmacoepidemiology 2023,32(8):878-885.
6798 times 1492 times

Dan-Dan LU Sheng-Xiang WANG Shan LU Dan PAN Li-Yuan SHI Fei-Chuang Jing2

Heart failure with reduced ejection fraction Sacubitril/valsartan Dapagliflozin Empagliflozin Markov model Cost-utility analysis
Details
The effects of Shensong Yangxin capsule combined with metoprolol tartrate on cardiac function, ventricular remodeling and safety in patients with heart failure complicated with ventricular arrhythmia

Published on Frontiers in Pharmaceutical Sciences 2023,36(10):104-110.
5894 times 1244 times

Bao-Liang GUO Zhan-Lu LI Xiao-Na LI

Shensong Yangxin capsule Metoprolol tartrate Heart failure Arrhythmia Ventricular remodeling
Details
Effects of recombinant human brain natriuretic peptide combined with levosimendan on cardiac function, myocardial fibrosis and safety in patients with acute heart failure

Published on Frontiers in Pharmaceutical Sciences 2023,36(11):264-271.
5435 times 1228 times

Sheng ZHANG Jin ZHU Xiao-Yu YANG

Recombinant human brain natriuretic peptide Levosimendan Acute heart failure Cardiac function
Details
Effects of dapagliflozin on myocardial work and energy metabolism in heart failure with reduced ejection fraction patients without type 2 diabetes mellitus

Published on Frontiers in Pharmaceutical Sciences 2024,27(1):100-108.
4861 times 1509 times

LU Qian DENG Yimin YANG Zongwang HUANG He QIN Peng LUO Weilin YE Shaowu

Dapagliflozin Heart failure with reduced ejection fraction Myocardial function Energy metabolism Diabetes
Details
Effects of beta-blockers for congestive heart failure in pediatric patients: Meta-analysis

Published on Frontiers in Pharmaceutical Sciences 2024,27(2):345-356.
6478 times 1294 times

WANG Yadan LI Hui LIU Jinping ZHANG Kunxian ZHAO Guoyan

Congestive heart failure Children β-blockers Left ventricular ejection fraction Meta-analysis
Details
Pharmaceutical care of acute liver injury caused by intravenous amiodarone in a patient with pulmonary embolism-induced heart failure

Published on Chinese Journal of Pharmacoepidemiology 2024,33(8):955-960.
7223 times 1410 times

HE Yang LIU Meng

Pulmonary embolism Heart failure Liver injury Amiodarone Pharmaceutical care
Details
Efficacy and safety of dapagliflozin combined with sacubitril valsartan in the treatment of heart failure after acute myocardial infarction: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(11):1254-1264.
8219 times 1450 times

BI Longfei LIU Yao LIU Bingxia LI Kui

Dapgliflozin Sacubitril valsartan Myocardial infarction Heart failure Meta-analysis Systematic review Randomized controlled trial
Details
Bibliometric analysis of research on gut microbiota in the prevention and treatment of heart failure

Published on New Medicine 2025,35(6):688-696.
4117 times 897 times

ZHANG Ruihang HUO Yanming WANG Huiqi WU Jing SUN Wei YUAN Yang WANG Shicheng LI Wei ZHOU Chengkun LIU Wenze

Gut microbiota Heart failure Bibliometrics VOSviewer CiteSpace
Details
Exploratory study on the protective mechanism of Campsis flos against cardiac injury after heart failure in mice

Published on Frontiers in Pharmaceutical Sciences 2025,29(6):901-911.
5723 times 692 times

LIU Zhiqiang WANG Kexin YANG Daixiao

Campsis flos Heart failure Aortic stenosis Mechanism of action
Details
Acute drug-induced liver injury associated with tolvaptan in a patient with cardiac amyloidosis: a case report

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1347-1352.
454 times 88 times

YAO Tingyi ZHANG Weixia

Tolvaptan Drug-induced liver injury AL cardiac amyloidosis Heart failure
Details